H.R. 920 (119th)Bill Overview

Federal Initiative to Guarantee Health by Targeting Fentanyl Act

Crime and Law Enforcement|Crime and Law EnforcementCriminal procedure and sentencing
Cosponsors
Support
Republican
Introduced
Feb 4, 2025
Discussions
Bill Text
Current stageCommittee

Referred to the Committee on Energy and Commerce, and in addition to the Committee on the Judiciary, for a period to be subsequently determined by the Speaker, in each case for co…

Introduced
Committee
Floor
President
Law
Congressional Activities
01 · The brief
Plain-English summaryWhat this bill actually does

This bill amends the Controlled Substances Act to add a broad category of "fentanyl-related substances" to Schedule I, defining the category by several classes of structural modifications. It also specifies that any mandatory minimum prison terms that would otherwise apply under a referenced penalty provision do not apply to substances described by the new fentanyl-related substances listing.

Why people may split

All agree on need to combat fentanyl, differ on sentencing and scope

Watch point

Relative to its intended legislative type, this bill is a direct and specific statutory amendment that clearly defines the operative legal change (adding a broad class of fentanyl-related substances to Schedule I and altering an applicable minimum sentence exemption).

This bill amends the Controlled Substances Act to add a broad category of "fentanyl-related substances" to Schedule I, defining the category by several classes of structural modifications.

It also specifies that any mandatory minimum prison terms that would otherwise apply under a referenced penalty provision do not apply to substances described by the new fentanyl-related substances listing.

Passage35/100

Narrow subject improves prospects, but broad structural scheduling, legal vagueness concerns, and Senate hurdles reduce overall likelihood.

CredibilityPartially aligned

Relative to its intended legislative type, this bill is a direct and specific statutory amendment that clearly defines the operative legal change (adding a broad class of fentanyl-related substances to Schedule I and altering an applicable minimum sentence exemption). It includes a relatively detailed definition mechanism but lacks implementation guidance, fiscal acknowledgment, edge-case safeguards, and accountability provisions.

Contention55/100

All agree on need to combat fentanyl, differ on sentencing and scope

02 · What it does

Who stands to gain, and who may push back.

Likely benefits vs burdens50% / 50%
Federal agenciesFederal agencies

These are examples from the analysis, not a ranked list of the most-affected groups.

Likely helped
  • Federal agenciesAllows federal authorities to regulate and seize a wide range of fentanyl analogs without listing each chemical individ…
  • Potential benefitEases prosecution of supply and distribution of novel fentanyl variants by covering structurally related substances.
  • Potential benefitMay reduce the availability of designer fentanyls on illicit markets, potentially lowering some overdose risks.
Likely burdened
  • Potential burdenThe chemical definition is broad and could unintentionally encompass benign or novel research compounds.
  • Potential burdenSchedule I designation imposes significant regulatory barriers that can hinder legitimate scientific and medical resear…
  • Federal agenciesBroad federal control may increase compliance costs for laboratories, manufacturers, and testing facilities.
03 · Why people split

Why the argument around this bill splits.

All agree on need to combat fentanyl, differ on sentencing and scope
Progressive60%

Generally supports measures that reduce overdose deaths and target illicit fentanyl, but worries the broad chemical definition could criminalize research, harm public-health approaches, and enable aggressive policing.

Praises removal of mandatory minimums but seeks explicit protections for treatment, harm reduction, and scientific research.

Split reaction
Centrist75%

Sees practical benefits in a clean legal tool against rapidly changing fentanyl analogs and likes the removal of mandatory minimums as a pragmatic balance.

Wants clearer statutory language about scope, research exemptions, and implementation to avoid unintended consequences.

Leans supportive
Conservative70%

Supports stronger legal tools against fentanyl trafficking and the scheduling of analogs, viewing this as a needed law-and-order measure.

However, objects to removing mandatory minimums, believing stricter penalties deter traffickers; may seek restoration of tougher sentencing.

Leans supportive
04 · Can it pass?

The path through Congress.

Introduced

Reached or meaningfully advanced

Committee

Reached or meaningfully advanced

Floor

Still ahead

President

Still ahead

Law

Still ahead

Passage likelihood35/100

Narrow subject improves prospects, but broad structural scheduling, legal vagueness concerns, and Senate hurdles reduce overall likelihood.

Scope and complexity
52%
Scopemoderate
52%
Complexitymedium
Why this could stall
  • Administrative implementation and DEA rulemaking timeline
  • Potential legal challenges on vagueness and scientific definition
05 · Recent votes

Recent votes on the bill.

No vote history yet

The bill has not accumulated any surfaced votes yet.

06 · Go deeper

Go deeper than the headline read.

Included on this page

All agree on need to combat fentanyl, differ on sentencing and scope

Narrow subject improves prospects, but broad structural scheduling, legal vagueness concerns, and Senate hurdles reduce overall likelihood.

Unlocked analysis

Relative to its intended legislative type, this bill is a direct and specific statutory amendment that clearly defines the operative legal change (adding a broad class of fentanyl-related substances to Schedule I and al…

Go beyond the headline summary with full stakeholder mapping, legislative design analysis, passage barriers, and lens-by-lens tradeoff breakdowns.

Perspective breakdownsPassage barriersLegislative design reviewStakeholder impact map
Open full analysis